KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Current Assets: 2020-2025

Historic Current Assets for AbCellera Biologics (ABCL) over the last 5 years, with Sep 2025 value amounting to $695.1 million.

  • AbCellera Biologics' Current Assets fell 6.43% to $695.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $695.1 million, marking a year-over-year decrease of 6.43%. This contributed to the annual value of $751.4 million for FY2024, which is 13.83% down from last year.
  • According to the latest figures from Q3 2025, AbCellera Biologics' Current Assets is $695.1 million, which was down 6.33% from $742.1 million recorded in Q2 2025.
  • AbCellera Biologics' 5-year Current Assets high stood at $1.2 billion for Q1 2022, and its period low was $695.1 million during Q3 2025.
  • In the last 3 years, AbCellera Biologics' Current Assets had a median value of $771.6 million in 2024 and averaged $813.2 million.
  • As far as peak fluctuations go, AbCellera Biologics' Current Assets spiked by 32.40% in 2022, and later fell by 19.90% in 2023.
  • AbCellera Biologics' Current Assets (Quarterly) stood at $929.8 million in 2021, then rose by 10.29% to $1.0 billion in 2022, then dropped by 14.97% to $872.0 million in 2023, then declined by 13.83% to $751.4 million in 2024, then fell by 6.43% to $695.1 million in 2025.
  • Its Current Assets stands at $695.1 million for Q3 2025, versus $742.1 million for Q2 2025 and $765.0 million for Q1 2025.